Soleno Therapeutics Clears Key Benchmark, Hitting 90-Plus RS Rating

IBD's RS Rating tracks stock performance on a scale of 1 to 99, with scores above 80 indicating strong potential. Successful stock investing involves monitoring buying opportunities and technical indicators like the Relative Strength Line for informed decisions.